Thymidine Kinase 2 (TK2 ) Deficiency

DBCOND0171486Congenital, Hereditary, and Neonatal Diseases and Abnormalities

Thymidine Kinase 2 (TK2 ) Deficiency is the indication for 2 drugs in DrugBank. It is covered by 2 curated, structured indications.

Also known as
Thymidine Kinase 2 Deficiency
Classified under
Indicated drugs

Resolves to

Vocabularies
SNOMED CT1187535000MedDRA10059396UMLSC0342782

What you can answer from here — as of October 23, 2026

2Indicated drugsWith each drug's targets and mechanism
Listed above
2Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
5Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Drug reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Thymidine Kinase 2 (TK2 ) Deficiency share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In